Press releaseNature Biotechnology publishes research from DKFZ and Cellply highlighting novel approach for accelerating cellular immunotherapy development19 March 2024Read more
EventsDual attendance for Cellply at March’s leading events in the cell therapy industry.18 March 2024Read more
NewsCellply launches its end-to-end single cell potency characterization platform VivaCyte17 January 2024Read more
Press releaseCellply concludes a new internal round of €3.6 million and extends the round to new investors!27 September 2023Read more
EventsCellply to present new method for evaluating immunotherapy efficacy at the 61th ASH Annual Meeting25 November 2019Read more
NewsCellply wins the €300k Gaetano Marzotto prize and Unicredit StartLab prize22 November 2018Read more
Press releaseCellply secures €2.34m non-dilutive grant funding from the European Commission for a novel precision oncology diagnostic platform24 May 2018Read more
Press releaseCellply and Sant’Orsola-Malpighi Polyclinic to present one abstract on AML patient stratification with the Open Microwell platform at the 58th ASH Annual Meeting4 November 2016Read more